JG
CORT icon

Jain Global’s Corcept Therapeutics CORT Stock Holding History

Jain Global’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31,792
Closed -$2.33M – 1100
2025
Q2 		$2.33M Buy
+31,792
New +$2.3M 0.02% 468
2025
Q1 		– Sell
-19,837
Closed -$1,000K – 1121
2024
Q4 		$1,000K Buy
+19,837
New +$1.04M 0.03% 326

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jain Global's CORT Position: Q3 2025 in Review

Jain Global sold out of Corcept Therapeutics (CORT) in Q3 2025, closing a stake of 31,792 shares — an estimated $2.33M sold.

Jain Global first reported a position in CORT in Q4 2024 and held it in 2 quarters. The position peaked at $2.33M in Q2 2025. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

  • Jain Global reported no remaining Corcept Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jain Global sold 31,792 Corcept Therapeutics shares in Q3 2025, an estimated $2.33M.
  • Jain Global first reported a position in Corcept Therapeutics in Q4 2024 and held it in 2 quarters.
  • Jain Global's Corcept Therapeutics position peaked at $2.33M in Q2 2025.
  • 429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.